, 2020 Subject Management’ discussion and analysis for the fiscal year ended December 31, 2019 To President The Stock Exchange of Thailand Interpharma Public Company Limited ( “ the Company” ) would like
วันที่ 25 กุมภาพันธ์ 2558 May 13, 2019 Subject: Management’s Explanation and Analysis for the 3 months period ended March 31, 2019 Attention: Director and Manager The Stock Exchange of Thailand LDC
President The Stock Exchange of Thailand Takuni Group Public Company Limited (“The Company”) and its subsidiaries (“The Group”) would like to clarify the change in operating result for the period ended 31
Version) 5/ Full Version Statement of Comprehensive Income (MB.) 2021 (01/01/21 -31/12/21) 2020 (01/01/20 -31/12/20) 2019 (01/01/19 -31/12/19) 2018 (01/01/18 -31/12/18) Accounting Type
) Reports on Acquisition or Disposition of Securities (246-2) Financial Statements (Concise Version) 5/ Full Version Statement of Comprehensive Income (MB.) 2021 (01/01/21 -31/12/21) 2020 (01/01/20 -31
-2) Financial Statements (Concise Version) 5/ Full Version Statement of Comprehensive Income (MB.) 2021 (01/01/21 -31/12/21) 2020 (01/01/20 -31/12/20) 2019 (01/01/19 -31/12/19) 2018 (01/01/18
changes in securities holding report (59-2) Reports on Acquisition or Disposition of Securities (246-2) Financial Statements (Concise Version) 5/ Full Version Statement of Comprehensive Income (MB.) 2021
Statement of Comprehensive Income (MB.) 2021 (01/01/21 -31/12/21) 2020 (01/01/20 -31/12/20) 2019 (01/01/19 -31/12/19) Accounting Type Consolidate Consolidate Consolidate Revenue From Operations
-Translation- Ref. WINNER 006/2020 February 27, 2020 Subject: Management Discussion and Analysis (MD & A) for the year 2019 To: The President The Stock Exchange of Thailand 1. Analysis of Overall
-Translation- Ref. WINNER 006/2020 February 27, 2020 Subject: Management Discussion and Analysis (MD & A) for the year 2019 (Revised) To: The President The Stock Exchange of Thailand 1. Analysis of